Form 4: Molina Healthcare Director Acquires Shares

Sentiment:

Insider Transaction Report


Molina Healthcare Director Richard M. Schapiro acquired 285 shares of common stock as part of his director compensation plan.

Summary

  • Richard M. Schapiro, a Director of Molina Healthcare, Inc. (MOH), acquired 285 shares of common stock on October 1, 2025.
  • The acquisition was a grant of stock under the Issuer's 2025 Equity Incentive Plan, in connection with services as a Director.
  • The shares were granted at a price of $192.79 per share, which was the closing price of Molina Healthcare's common stock on the transaction date.
  • The aggregate dollar value of the annual equity award to each director is set at $220,000, with one quarter, or $55,000, granted on the first day of each quarter.
  • Following this transaction, Richard M. Schapiro beneficially owns a total of 11,709 shares of Molina Healthcare common stock.

Sentiment

Score: 6

Explanation: Slightly positive, as it reflects a routine, pre-planned director compensation grant that increases insider ownership and aligns interests with shareholders, without indicating any negative operational or financial news.

Positives

  • The acquisition of shares by a director increases their direct ownership stake, aligning their interests more closely with those of shareholders.
  • The grant is part of a pre-established equity incentive plan, indicating a structured approach to director compensation and long-term alignment.

Future Outlook

The filing indicates that the director's equity awards are part of an ongoing 2025 Equity Incentive Plan, with quarterly grants expected based on the closing price of the common stock.

Industry Context

This transaction represents a routine insider filing related to director compensation, a common practice across publicly traded companies to align management and board interests with shareholders.

Comparison to Industry Standards

  • Director equity compensation, structured as quarterly grants under an incentive plan, is a standard practice in corporate governance across various industries, including healthcare.
  • The use of a Power of Attorney for SEC filings is also a common administrative measure to ensure timely compliance for directors and officers.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive PlanGrant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.10/01/2025Aligns director interests with shareholders through equity ownership, promoting long-term value creation.
Power of AttorneyLimited Power of Attorney granted to Jeff D. Barlow and Codruta Boggs to execute Section 16(a) filings (Forms 3, 4, and 5) for Richard M. Schapiro.07/29/2015Streamlines compliance with SEC reporting requirements for insider transactions, ensuring timely and accurate disclosures.

Related Party Transactions

  • The stock grant to Director Richard M. Schapiro constitutes a related party transaction, as it is compensation provided by the company to a member of its board of directors.

Stakeholder Impact

  • Shareholders: Increased director ownership may be viewed positively as it aligns the director's financial interests with those of the shareholders.
  • Employees: No direct impact indicated by this filing.

Next Steps

  • Future quarterly grants of common stock to directors are expected under the 2025 Equity Incentive Plan, based on the closing price of the Issuer's common stock on the first day of each quarter.

Key Dates

DateDescription
07/29/2015Date Limited Power of Attorney was executed by Richard M. Schapiro.
10/01/2025Date of the common stock acquisition by Richard M. Schapiro.
10/02/2025Date the Form 4 was signed by power of attorney.

Recommendation

hold

This Form 4 filing details a routine, pre-scheduled equity compensation grant to a director. It does not contain any new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment thesis. While increased insider ownership is generally positive, this specific transaction is expected and does not provide a basis for a 'buy' or 'sell' recommendation; therefore, a 'hold' is appropriate for existing investors.

Keywords

Molina Healthcare, MOH, Richard M. Schapiro, Director, Insider Transaction, Stock Grant, Equity Incentive Plan, Director Compensation, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.